Global Hepatic Encephalopathy Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Hepatic Encephalopathy Treatment market size was valued at USD 1529 million in 2022 and is forecast to a readjusted size of USD 2332.8 million by 2029 with a CAGR of 6.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hepatic encephalopathy (HE) treatment aims to manage the symptoms and underlying causes of the condition. HE is a condition where the liver is unable to remove toxins from the bloodstream effectively, leading to a buildup of toxins in the brain. The condition can range from mild to severe, with symptoms such as confusion, personality changes, tremors, and even coma.
This report is a detailed and comprehensive analysis for global Hepatic Encephalopathy Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Route and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hepatic Encephalopathy Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatic Encephalopathy Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatic Encephalopathy Treatment market size and forecasts, by Route and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatic Encephalopathy Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hepatic Encephalopathy Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hepatic Encephalopathy Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc. and ASKA Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hepatic Encephalopathy Treatment market is split by Route and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Route, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Route
Chapter 1, to describe Hepatic Encephalopathy Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hepatic Encephalopathy Treatment, with price, sales, revenue and global market share of Hepatic Encephalopathy Treatment from 2018 to 2023.
Chapter 3, the Hepatic Encephalopathy Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatic Encephalopathy Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Route and application, with sales market share and growth rate by route, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hepatic Encephalopathy Treatment market forecast, by regions, route and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatic Encephalopathy Treatment.
Chapter 14 and 15, to describe Hepatic Encephalopathy Treatment sales channel, distributors, customers, research findings and conclusion.
Hepatic encephalopathy (HE) treatment aims to manage the symptoms and underlying causes of the condition. HE is a condition where the liver is unable to remove toxins from the bloodstream effectively, leading to a buildup of toxins in the brain. The condition can range from mild to severe, with symptoms such as confusion, personality changes, tremors, and even coma.
This report is a detailed and comprehensive analysis for global Hepatic Encephalopathy Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Route and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hepatic Encephalopathy Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatic Encephalopathy Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatic Encephalopathy Treatment market size and forecasts, by Route and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hepatic Encephalopathy Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hepatic Encephalopathy Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hepatic Encephalopathy Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc. and ASKA Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hepatic Encephalopathy Treatment market is split by Route and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Route, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Route
- Oral
- Injectable
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Mallinckrodt Pharmaceuticals
- Salix Pharmaceuticals
- GlaxoSmithKline plc.
- Pfizer Inc.
- ASKA Pharmaceutical Co., Ltd.
- Bausch Health
- Johnson & Johnson Services, Inc.
- Janssen Global Services
- Takeda Pharmaceutical Company Limited
- Merck & Co., Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Hepatic Encephalopathy Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hepatic Encephalopathy Treatment, with price, sales, revenue and global market share of Hepatic Encephalopathy Treatment from 2018 to 2023.
Chapter 3, the Hepatic Encephalopathy Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatic Encephalopathy Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Route and application, with sales market share and growth rate by route, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hepatic Encephalopathy Treatment market forecast, by regions, route and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatic Encephalopathy Treatment.
Chapter 14 and 15, to describe Hepatic Encephalopathy Treatment sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hepatic Encephalopathy Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Route
1.3.1 Overview: Global Hepatic Encephalopathy Treatment Consumption Value by Route: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Injectable
1.4 Market Analysis by Application
1.4.1 Overview: Global Hepatic Encephalopathy Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Hepatic Encephalopathy Treatment Market Size & Forecast
1.5.1 Global Hepatic Encephalopathy Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hepatic Encephalopathy Treatment Sales Quantity (2018-2029)
1.5.3 Global Hepatic Encephalopathy Treatment Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Mallinckrodt Pharmaceuticals
2.1.1 Mallinckrodt Pharmaceuticals Details
2.1.2 Mallinckrodt Pharmaceuticals Major Business
2.1.3 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
2.1.4 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.2 Salix Pharmaceuticals
2.2.1 Salix Pharmaceuticals Details
2.2.2 Salix Pharmaceuticals Major Business
2.2.3 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
2.2.4 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Salix Pharmaceuticals Recent Developments/Updates
2.3 GlaxoSmithKline plc.
2.3.1 GlaxoSmithKline plc. Details
2.3.2 GlaxoSmithKline plc. Major Business
2.3.3 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
2.3.4 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline plc. Recent Developments/Updates
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
2.4.4 Pfizer Inc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Inc. Recent Developments/Updates
2.5 ASKA Pharmaceutical Co., Ltd.
2.5.1 ASKA Pharmaceutical Co., Ltd. Details
2.5.2 ASKA Pharmaceutical Co., Ltd. Major Business
2.5.3 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
2.5.4 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Hepatic Encephalopathy Treatment Product and Services
2.6.4 Bausch Health Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bausch Health Recent Developments/Updates
2.7 Johnson & Johnson Services, Inc.
2.7.1 Johnson & Johnson Services, Inc. Details
2.7.2 Johnson & Johnson Services, Inc. Major Business
2.7.3 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
2.7.4 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
2.8 Janssen Global Services
2.8.1 Janssen Global Services Details
2.8.2 Janssen Global Services Major Business
2.8.3 Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
2.8.4 Janssen Global Services Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Janssen Global Services Recent Developments/Updates
2.9 Takeda Pharmaceutical Company Limited
2.9.1 Takeda Pharmaceutical Company Limited Details
2.9.2 Takeda Pharmaceutical Company Limited Major Business
2.9.3 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
2.9.4 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.10 Merck & Co., Inc.
2.10.1 Merck & Co., Inc. Details
2.10.2 Merck & Co., Inc. Major Business
2.10.3 Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
2.10.4 Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck & Co., Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HEPATIC ENCEPHALOPATHY TREATMENT BY MANUFACTURER
3.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hepatic Encephalopathy Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hepatic Encephalopathy Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hepatic Encephalopathy Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Hepatic Encephalopathy Treatment Manufacturer Market Share in 2022
3.5 Hepatic Encephalopathy Treatment Market: Overall Company Footprint Analysis
3.5.1 Hepatic Encephalopathy Treatment Market: Region Footprint
3.5.2 Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
3.5.3 Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Hepatic Encephalopathy Treatment Market Size by Region
4.1.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Hepatic Encephalopathy Treatment Average Price by Region (2018-2029)
4.2 North America Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.3 Europe Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.5 South America Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
5 MARKET SEGMENT BY ROUTE
5.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
5.2 Global Hepatic Encephalopathy Treatment Consumption Value by Route (2018-2029)
5.3 Global Hepatic Encephalopathy Treatment Average Price by Route (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
6.2 Global Hepatic Encephalopathy Treatment Consumption Value by Application (2018-2029)
6.3 Global Hepatic Encephalopathy Treatment Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
7.2 North America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
7.3 North America Hepatic Encephalopathy Treatment Market Size by Country
7.3.1 North America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
8.2 Europe Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Hepatic Encephalopathy Treatment Market Size by Country
8.3.1 Europe Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
9.2 Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hepatic Encephalopathy Treatment Market Size by Region
9.3.1 Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
10.2 South America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
10.3 South America Hepatic Encephalopathy Treatment Market Size by Country
10.3.1 South America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
11.2 Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hepatic Encephalopathy Treatment Market Size by Country
11.3.1 Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Hepatic Encephalopathy Treatment Market Drivers
12.2 Hepatic Encephalopathy Treatment Market Restraints
12.3 Hepatic Encephalopathy Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Hepatic Encephalopathy Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hepatic Encephalopathy Treatment
13.3 Hepatic Encephalopathy Treatment Production Process
13.4 Hepatic Encephalopathy Treatment Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hepatic Encephalopathy Treatment Typical Distributors
14.3 Hepatic Encephalopathy Treatment Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Hepatic Encephalopathy Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Route
1.3.1 Overview: Global Hepatic Encephalopathy Treatment Consumption Value by Route: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Injectable
1.4 Market Analysis by Application
1.4.1 Overview: Global Hepatic Encephalopathy Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Hepatic Encephalopathy Treatment Market Size & Forecast
1.5.1 Global Hepatic Encephalopathy Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hepatic Encephalopathy Treatment Sales Quantity (2018-2029)
1.5.3 Global Hepatic Encephalopathy Treatment Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Mallinckrodt Pharmaceuticals
2.1.1 Mallinckrodt Pharmaceuticals Details
2.1.2 Mallinckrodt Pharmaceuticals Major Business
2.1.3 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
2.1.4 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.2 Salix Pharmaceuticals
2.2.1 Salix Pharmaceuticals Details
2.2.2 Salix Pharmaceuticals Major Business
2.2.3 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
2.2.4 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Salix Pharmaceuticals Recent Developments/Updates
2.3 GlaxoSmithKline plc.
2.3.1 GlaxoSmithKline plc. Details
2.3.2 GlaxoSmithKline plc. Major Business
2.3.3 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
2.3.4 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline plc. Recent Developments/Updates
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
2.4.4 Pfizer Inc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Inc. Recent Developments/Updates
2.5 ASKA Pharmaceutical Co., Ltd.
2.5.1 ASKA Pharmaceutical Co., Ltd. Details
2.5.2 ASKA Pharmaceutical Co., Ltd. Major Business
2.5.3 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
2.5.4 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Hepatic Encephalopathy Treatment Product and Services
2.6.4 Bausch Health Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bausch Health Recent Developments/Updates
2.7 Johnson & Johnson Services, Inc.
2.7.1 Johnson & Johnson Services, Inc. Details
2.7.2 Johnson & Johnson Services, Inc. Major Business
2.7.3 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
2.7.4 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
2.8 Janssen Global Services
2.8.1 Janssen Global Services Details
2.8.2 Janssen Global Services Major Business
2.8.3 Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
2.8.4 Janssen Global Services Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Janssen Global Services Recent Developments/Updates
2.9 Takeda Pharmaceutical Company Limited
2.9.1 Takeda Pharmaceutical Company Limited Details
2.9.2 Takeda Pharmaceutical Company Limited Major Business
2.9.3 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
2.9.4 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.10 Merck & Co., Inc.
2.10.1 Merck & Co., Inc. Details
2.10.2 Merck & Co., Inc. Major Business
2.10.3 Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
2.10.4 Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck & Co., Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HEPATIC ENCEPHALOPATHY TREATMENT BY MANUFACTURER
3.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hepatic Encephalopathy Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hepatic Encephalopathy Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hepatic Encephalopathy Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Hepatic Encephalopathy Treatment Manufacturer Market Share in 2022
3.5 Hepatic Encephalopathy Treatment Market: Overall Company Footprint Analysis
3.5.1 Hepatic Encephalopathy Treatment Market: Region Footprint
3.5.2 Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
3.5.3 Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Hepatic Encephalopathy Treatment Market Size by Region
4.1.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Hepatic Encephalopathy Treatment Average Price by Region (2018-2029)
4.2 North America Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.3 Europe Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.5 South America Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Hepatic Encephalopathy Treatment Consumption Value (2018-2029)
5 MARKET SEGMENT BY ROUTE
5.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
5.2 Global Hepatic Encephalopathy Treatment Consumption Value by Route (2018-2029)
5.3 Global Hepatic Encephalopathy Treatment Average Price by Route (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
6.2 Global Hepatic Encephalopathy Treatment Consumption Value by Application (2018-2029)
6.3 Global Hepatic Encephalopathy Treatment Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
7.2 North America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
7.3 North America Hepatic Encephalopathy Treatment Market Size by Country
7.3.1 North America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
8.2 Europe Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Hepatic Encephalopathy Treatment Market Size by Country
8.3.1 Europe Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
9.2 Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hepatic Encephalopathy Treatment Market Size by Region
9.3.1 Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
10.2 South America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
10.3 South America Hepatic Encephalopathy Treatment Market Size by Country
10.3.1 South America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2029)
11.2 Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hepatic Encephalopathy Treatment Market Size by Country
11.3.1 Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Hepatic Encephalopathy Treatment Market Drivers
12.2 Hepatic Encephalopathy Treatment Market Restraints
12.3 Hepatic Encephalopathy Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Hepatic Encephalopathy Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hepatic Encephalopathy Treatment
13.3 Hepatic Encephalopathy Treatment Production Process
13.4 Hepatic Encephalopathy Treatment Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hepatic Encephalopathy Treatment Typical Distributors
14.3 Hepatic Encephalopathy Treatment Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Hepatic Encephalopathy Treatment Consumption Value by Route, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hepatic Encephalopathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Mallinckrodt Pharmaceuticals Major Business
Table 5. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 6. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 8. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Salix Pharmaceuticals Major Business
Table 10. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 11. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Salix Pharmaceuticals Recent Developments/Updates
Table 13. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline plc. Major Business
Table 15. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
Table 16. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline plc. Recent Developments/Updates
Table 18. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Inc. Major Business
Table 20. Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
Table 21. Pfizer Inc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Inc. Recent Developments/Updates
Table 23. ASKA Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. ASKA Pharmaceutical Co., Ltd. Major Business
Table 25. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
Table 26. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 29. Bausch Health Major Business
Table 30. Bausch Health Hepatic Encephalopathy Treatment Product and Services
Table 31. Bausch Health Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bausch Health Recent Developments/Updates
Table 33. Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Services, Inc. Major Business
Table 35. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
Table 36. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 38. Janssen Global Services Basic Information, Manufacturing Base and Competitors
Table 39. Janssen Global Services Major Business
Table 40. Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
Table 41. Janssen Global Services Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Janssen Global Services Recent Developments/Updates
Table 43. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Pharmaceutical Company Limited Major Business
Table 45. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
Table 46. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 48. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Merck & Co., Inc. Major Business
Table 50. Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
Table 51. Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck & Co., Inc. Recent Developments/Updates
Table 53. Global Hepatic Encephalopathy Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Hepatic Encephalopathy Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Hepatic Encephalopathy Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Hepatic Encephalopathy Treatment Production Site of Key Manufacturer
Table 58. Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
Table 59. Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
Table 60. Hepatic Encephalopathy Treatment New Market Entrants and Barriers to Market Entry
Table 61. Hepatic Encephalopathy Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Hepatic Encephalopathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Hepatic Encephalopathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Hepatic Encephalopathy Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Hepatic Encephalopathy Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 69. Global Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 70. Global Hepatic Encephalopathy Treatment Consumption Value by Route (2018-2023) & (USD Million)
Table 71. Global Hepatic Encephalopathy Treatment Consumption Value by Route (2024-2029) & (USD Million)
Table 72. Global Hepatic Encephalopathy Treatment Average Price by Route (2018-2023) & (US$/Unit)
Table 73. Global Hepatic Encephalopathy Treatment Average Price by Route (2024-2029) & (US$/Unit)
Table 74. Global Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Hepatic Encephalopathy Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Hepatic Encephalopathy Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Hepatic Encephalopathy Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Hepatic Encephalopathy Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 81. North America Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 82. North America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Hepatic Encephalopathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Hepatic Encephalopathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 89. Europe Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 90. Europe Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Hepatic Encephalopathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Hepatic Encephalopathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 97. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 98. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 105. South America Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 106. South America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Hepatic Encephalopathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Hepatic Encephalopathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 113. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 114. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Hepatic Encephalopathy Treatment Raw Material
Table 121. Key Manufacturers of Hepatic Encephalopathy Treatment Raw Materials
Table 122. Hepatic Encephalopathy Treatment Typical Distributors
Table 123. Hepatic Encephalopathy Treatment Typical Customers
Table 1. Global Hepatic Encephalopathy Treatment Consumption Value by Route, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hepatic Encephalopathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Mallinckrodt Pharmaceuticals Major Business
Table 5. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 6. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 8. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Salix Pharmaceuticals Major Business
Table 10. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product and Services
Table 11. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Salix Pharmaceuticals Recent Developments/Updates
Table 13. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline plc. Major Business
Table 15. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product and Services
Table 16. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline plc. Recent Developments/Updates
Table 18. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Inc. Major Business
Table 20. Pfizer Inc. Hepatic Encephalopathy Treatment Product and Services
Table 21. Pfizer Inc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Inc. Recent Developments/Updates
Table 23. ASKA Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. ASKA Pharmaceutical Co., Ltd. Major Business
Table 25. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product and Services
Table 26. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 29. Bausch Health Major Business
Table 30. Bausch Health Hepatic Encephalopathy Treatment Product and Services
Table 31. Bausch Health Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bausch Health Recent Developments/Updates
Table 33. Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Services, Inc. Major Business
Table 35. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product and Services
Table 36. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 38. Janssen Global Services Basic Information, Manufacturing Base and Competitors
Table 39. Janssen Global Services Major Business
Table 40. Janssen Global Services Hepatic Encephalopathy Treatment Product and Services
Table 41. Janssen Global Services Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Janssen Global Services Recent Developments/Updates
Table 43. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Pharmaceutical Company Limited Major Business
Table 45. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product and Services
Table 46. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 48. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Merck & Co., Inc. Major Business
Table 50. Merck & Co., Inc. Hepatic Encephalopathy Treatment Product and Services
Table 51. Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck & Co., Inc. Recent Developments/Updates
Table 53. Global Hepatic Encephalopathy Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Hepatic Encephalopathy Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Hepatic Encephalopathy Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Hepatic Encephalopathy Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Hepatic Encephalopathy Treatment Production Site of Key Manufacturer
Table 58. Hepatic Encephalopathy Treatment Market: Company Product Type Footprint
Table 59. Hepatic Encephalopathy Treatment Market: Company Product Application Footprint
Table 60. Hepatic Encephalopathy Treatment New Market Entrants and Barriers to Market Entry
Table 61. Hepatic Encephalopathy Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Hepatic Encephalopathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Hepatic Encephalopathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Hepatic Encephalopathy Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Hepatic Encephalopathy Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 69. Global Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 70. Global Hepatic Encephalopathy Treatment Consumption Value by Route (2018-2023) & (USD Million)
Table 71. Global Hepatic Encephalopathy Treatment Consumption Value by Route (2024-2029) & (USD Million)
Table 72. Global Hepatic Encephalopathy Treatment Average Price by Route (2018-2023) & (US$/Unit)
Table 73. Global Hepatic Encephalopathy Treatment Average Price by Route (2024-2029) & (US$/Unit)
Table 74. Global Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Hepatic Encephalopathy Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Hepatic Encephalopathy Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Hepatic Encephalopathy Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Hepatic Encephalopathy Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 81. North America Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 82. North America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Hepatic Encephalopathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Hepatic Encephalopathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 89. Europe Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 90. Europe Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Hepatic Encephalopathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Hepatic Encephalopathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 97. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 98. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 105. South America Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 106. South America Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Hepatic Encephalopathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Hepatic Encephalopathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Hepatic Encephalopathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Hepatic Encephalopathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Route (2018-2023) & (K Units)
Table 113. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Route (2024-2029) & (K Units)
Table 114. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Hepatic Encephalopathy Treatment Raw Material
Table 121. Key Manufacturers of Hepatic Encephalopathy Treatment Raw Materials
Table 122. Hepatic Encephalopathy Treatment Typical Distributors
Table 123. Hepatic Encephalopathy Treatment Typical Customers
LIST OF FIGURES
Figure 1. Hepatic Encephalopathy Treatment Picture
Figure 2. Global Hepatic Encephalopathy Treatment Consumption Value by Route, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Route in 2022
Figure 4. Oral Examples
Figure 5. Injectable Examples
Figure 6. Global Hepatic Encephalopathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacy Examples
Figure 9. Retail Pharmacy Examples
Figure 10. Online Pharmacy Examples
Figure 11. Global Hepatic Encephalopathy Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Hepatic Encephalopathy Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Hepatic Encephalopathy Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Hepatic Encephalopathy Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Hepatic Encephalopathy Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Hepatic Encephalopathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Hepatic Encephalopathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 28. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Route (2018-2029)
Figure 29. Global Hepatic Encephalopathy Treatment Average Price by Route (2018-2029) & (US$/Unit)
Figure 30. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Hepatic Encephalopathy Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 34. North America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Hepatic Encephalopathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 41. Europe Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Hepatic Encephalopathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Hepatic Encephalopathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 50. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 60. South America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Hepatic Encephalopathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 66. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Hepatic Encephalopathy Treatment Market Drivers
Figure 74. Hepatic Encephalopathy Treatment Market Restraints
Figure 75. Hepatic Encephalopathy Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Treatment in 2022
Figure 78. Manufacturing Process Analysis of Hepatic Encephalopathy Treatment
Figure 79. Hepatic Encephalopathy Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Hepatic Encephalopathy Treatment Picture
Figure 2. Global Hepatic Encephalopathy Treatment Consumption Value by Route, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Route in 2022
Figure 4. Oral Examples
Figure 5. Injectable Examples
Figure 6. Global Hepatic Encephalopathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacy Examples
Figure 9. Retail Pharmacy Examples
Figure 10. Online Pharmacy Examples
Figure 11. Global Hepatic Encephalopathy Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Hepatic Encephalopathy Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Hepatic Encephalopathy Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Hepatic Encephalopathy Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Hepatic Encephalopathy Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Hepatic Encephalopathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Hepatic Encephalopathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 28. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Route (2018-2029)
Figure 29. Global Hepatic Encephalopathy Treatment Average Price by Route (2018-2029) & (US$/Unit)
Figure 30. Global Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Hepatic Encephalopathy Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Hepatic Encephalopathy Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 34. North America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Hepatic Encephalopathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 41. Europe Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Hepatic Encephalopathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Hepatic Encephalopathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 50. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Hepatic Encephalopathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Hepatic Encephalopathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 60. South America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Hepatic Encephalopathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Hepatic Encephalopathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity Market Share by Route (2018-2029)
Figure 66. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Hepatic Encephalopathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Hepatic Encephalopathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Hepatic Encephalopathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Hepatic Encephalopathy Treatment Market Drivers
Figure 74. Hepatic Encephalopathy Treatment Market Restraints
Figure 75. Hepatic Encephalopathy Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Treatment in 2022
Figure 78. Manufacturing Process Analysis of Hepatic Encephalopathy Treatment
Figure 79. Hepatic Encephalopathy Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
